Cutting Sterility Test Timelines: A New Approach to Automated Validation

[Article Title]

Sterility testing remains one of the last and most important controls before releasing sterile pharmaceutical products. In this article, learn about a new, automated, growth-based rapid sterility system that mirrors pharmacopeial methods while cutting time to result dramatically.

You'll get an inside look at:

  • How the system replicates the three compendial growth zones using membrane filtration and a single engineered anaerobic cassette
  • Why continuous fluorescence-based imaging every four hours can catch slow-growing "tail" organisms that broth-based methods might miss
  • The five core validation requirements (specificity, limit of detection, equivalence, suitability, and more) under USP <1223>, Ph. Eur. 5.1.6, and PDA TR 33
  • A structured, step-by-step validation strategy from IQ/OQ through method suitability

Download the full article to see how QC microbiology labs can move toward faster, more data-rich sterility testing without abandoning the growth-based science regulators already trust.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.